These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9122912)

  • 1. Relative sensitivity of United States and European assays for screening blood donors for antibodies to human immunodeficiency viruses.
    Busch MP; Couroucé AM
    Transfusion; 1997 Mar; 37(3):352-4. PubMed ID: 9122912
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
    Dogbe EE; Arthur F
    Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening blood donors for human immunodeficiency virus antibody: cost-benefit analysis.
    Eisenstaedt RS; Getzen TE
    Am J Public Health; 1988 Apr; 78(4):450-4. PubMed ID: 3126676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.
    Roth WK; Weber M; Buhr S; Drosten C; Weichert W; Sireis W; Hedges D; Seifried E
    Transfusion; 2002 Jul; 42(7):862-8. PubMed ID: 12375658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening blood donors for HTLV-III antibody.
    Mann DA
    JAMA; 1986 Nov; 256(17):2344-5. PubMed ID: 3534328
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple unconfirmed-reactive screening tests for viral antibodies among blood donors.
    Buffington J; Shapiro CN; Holman RC; Strine TW; Grossman BJ; Williams AE; Alter MJ; Schonberger LB
    Transfusion; 1994 May; 34(5):371-5. PubMed ID: 8191558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an enzyme immunoassay for detection of antibody to human immunodeficiency virus in low risk populations.
    Peetoom F
    Transfusion; 1986; 26(6):536-8. PubMed ID: 3535179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV antibody screening of corneal donors.
    Wilhelmus KR; Farge EJ
    Ophthalmologica; 1987; 195(2):57-60. PubMed ID: 3313150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food and Drug Administration conference on the feasibility of genetic technology to close the HIV window in donor screening.
    Hewlett IK; Epstein JS
    Transfusion; 1997 Mar; 37(3):346-51. PubMed ID: 9122911
    [No Abstract]   [Full Text] [Related]  

  • 10. Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
    Malm K; Kragsbjerg E; Andersson S
    Transfus Med; 2015 Apr; 25(2):101-5. PubMed ID: 25779614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update: serologic testing for antibody to human immunodeficiency virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jan; 36(52):833-40, 845. PubMed ID: 3121999
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in organizing research on donor blood for the presence of antibodies to the human immunodeficiency virus].
    Koroliuk AM; Sboĭchakov VB; Medvedev ML; Andreeva LS; Plakhotnikov AIa
    Voen Med Zh; 1988 Apr; (4):41. PubMed ID: 3046128
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in postmortem blood specimens using infectious disease assays licensed for cadaveric donor screening.
    Greenwald MA; Kerby S; Francis K; Noller AC; Gormley WT; Biswas R; Forshee RA
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leads from the MMWR. Update: serologic testing for antibody to human immunodeficiency virus.
    JAMA; 1988 Feb; 259(5):653, 656, 662-4. PubMed ID: 3275818
    [No Abstract]   [Full Text] [Related]  

  • 16. [Donors with positive antibodies against HIV virus in Red Cross blood banks].
    Franco E; Picazo J; Mazón C; Antich JL; Lafulla C; Ribó E; Contreras E
    Sangre (Barc); 1986; 31(6):775-6. PubMed ID: 3470958
    [No Abstract]   [Full Text] [Related]  

  • 17. Counseling HIV-antibody positive blood donors.
    Van Devanter NL; Grisaffi JA; Steilen M; Scarola ME; Shipton RM; Tendler C; Pindyck J
    Am J Nurs; 1987 Aug; 87(8):1026-30. PubMed ID: 3474900
    [No Abstract]   [Full Text] [Related]  

  • 18. [HIV and other retroviruses in the screening of blood donors].
    Bonanni G; D'Ambrosio F; Marino S
    Recenti Prog Med; 1991 Feb; 82(2):122-4. PubMed ID: 2034869
    [No Abstract]   [Full Text] [Related]  

  • 19. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses.
    Candotti D; Mundy C; Kadewele G; Nkhoma W; Bates I; Allain JP
    J Med Virol; 2001 Sep; 65(1):1-5. PubMed ID: 11505436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid phase red cell adherence immunoassay for anti-HIV 1: a simple, rapid, and accurate method for donor screening.
    Watson-Williams EJ; Yee JL; Carlson JR; Mertens SC; Holland P; Sinor L; Plapp FV
    Transfusion; 1988; 28(2):184-6. PubMed ID: 3162621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.